SHE:002581 Revenue

In the year 2025, Shandong Sinobioway Biomedicine had annual revenue of 274.81M CNY, down -23.75%. Shandong Sinobioway Biomedicine had revenue of 62.76M in the quarter ending December 31, 2025, with 37.35% growth.

Revenue

274.81M

Revenue Growth

-23.75%

P/S Ratio

17.07

Revenue / Employee

577.33K

Employees

476

Market Cap

4.69B

Revenue Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	274.81M	-85.60M	-23.75%
Dec 31, 2024	360.41M	-69.39M	-16.14%
Dec 31, 2023	429.79M	72.71M	20.36%
Jan 1, 2023	357.08M	-45.63M	-11.33%
Jan 1, 2022	402.71M	125.88M	45.47%
Dec 31, 2020	Pro	Pro	Pro
Dec 31, 2019	Pro	Pro	Pro
Dec 31, 2018	Pro	Pro	Pro
Dec 31, 2017	Pro	Pro	Pro
Dec 31, 2016	Pro	Pro	Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
Newland Pharmaceutical	659.54M
Jinling Pharmaceutical Company	3.20B
Guizhou Sanli Pharmaceutical Co.,Ltd	1.68B
Tibet Weixinkang Medicine	1.16B
Shanghai Xiao Fang Pharmaceutical	504.59M
Zhuhai Rundu Pharmaceutical	1.19B
Wuhan Hiteck Biological Pharma Co.,Ltd	543.82M
Yabao Pharmaceutical Group	2.20B

Revenue Rankings